source · application/json
source_7c6f6486e39d4113
sha256 145c65a25d2946e26bd68153f1d155393f10e0afe3fbafccab22798fbda2a781
by researka:v2 · 2026-07-10 12:09:14.309444+04:00
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "d8f38608-04e9-4baf-a98a-b15cef29f955", "sources": [{"directness": "review-level", "doi": "10.1186/s12902-024-01805-z", "risk_of_bias": "not appraised in public sidecar", "study": "Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis"}, {"directness": "primary", "doi": "10.1111/jdi.13789", "risk_of_bias": "not appraised in public sidecar", "study": "A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg"}, {"directness": "primary", "doi": "10.1186/s40001-025-02836-5", "risk_of_bias": "not appraised in public sidecar", "study": "Comprehensive analysis of real-world data on liraglutide treatment in patients with obesity: a multicenter national study"}, {"directness": "review-level", "doi": "10.1186/s12905-025-03787-z", "risk_of_bias": "not appraised in public sidecar", "study": "The safety and efficacy of liraglutide combined with metformin in clinical treatment of polycystic ovary syndrome patients: a meta-analysis"}, {"directness": "primary", "doi": "10.1097/JS9.0000000000000990", "risk_of_bias": "not appraised in public sidecar", "study": "Boosting weight loss after conversional Roux-en-Y Gastric Bypass with liraglutide and placebo use. A double-blind-randomized controlled trial"}, {"directness": "review-level", "doi": "10.1186/s40001-025-02801-2", "risk_of_bias": "not appraised in public sidecar", "study": "Impact of liraglutide on albumin-to-creatinine ratio in type 2 diabetes mellitus: a meta-analysis"}, {"directness": "primary", "doi": "10.1038/s41591-025-04106-7", "risk_of_bias": "not appraised in public sidecar", "study": "Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trial"}, {"directness": "review-level", "doi": "10.3389/fphar.2025.1438318", "risk_of_bias": "not appraised in public sidecar", "study": "Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis"}, {"directness": "primary", "doi": "10.1097/MD.0000000000042155", "risk_of_bias": "not appraised in public sidecar", "study": "Is liraglutide safe and effective in the elderly obese patients?: A single center experience"}, {"directness": "review-level", "doi": "10.3803/EnM.2020.934", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials"}, {"directness": "primary", "doi": "10.1007/s00125-025-06446-y", "risk_of_bias": "not appraised in public sidecar", "study": "Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial"}, {"directness": "primary", "doi": "10.1111/dom.70393", "risk_of_bias": "not appraised in public sidecar", "study": "Mental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg"}, {"directness": "review-level", "doi": "10.1007/s12325-026-03523-5", "risk_of_bias": "not appraised in public sidecar", "study": "Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials"}, {"directness": "primary", "doi": "10.3390/medicina60030395", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Liraglutide, Empagliflozin and Their Combination on Left Atrial Strain and Arterial Function"}, {"directness": "review-level", "doi": "10.1007/s00423-025-03831-4", "risk_of_bias": "not appraised in public sidecar", "study": "GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome improvement: a systematic review and meta-analysis"}, {"directness": "primary", "doi": "10.1001/jamanetworkopen.2025.39848", "risk_of_bias": "not appraised in public sidecar", "study": "Liraglutide and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery"}, {"directness": "primary", "doi": "10.1186/s12902-025-01913-4", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study"}, {"directness": "primary", "doi": "10.1080/19490976.2025.2558071", "risk_of_bias": "not appraised in public sidecar", "study": "Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study"}, {"directness": "primary", "doi": "10.1161/STROKEAHA.125.056010", "risk_of_bias": "not appraised in public sidecar", "study": "Liraglutide and Recurrent Stroke by Baseline Insulin Resistance: A Post Hoc Analysis of the LAMP Trial"}, {"directness": "review-level", "doi": "10.1038/s41598-025-09807-0", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and safety of GLP-1 agonists in the treatment of T2DM: A systematic review and network meta-analysis"}, {"directness": "primary", "doi": "10.1002/jcsm.13445", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial"}, {"directness": "primary", "doi": "10.1111/dom.16395", "risk_of_bias": "not appraised in public sidecar", "study": "The influence of the glucagon‐like peptide‐1 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: A secondary analysis of a randomized controlled trial"}, {"directness": "primary", "doi": "10.1186/s12933-025-02706-8", "risk_of_bias": "not appraised in public sidecar", "study": "Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes"}, {"directness": "primary", "doi": "10.1111/dom.16419", "risk_of_bias": "not appraised in public sidecar", "study": "Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial"}, {"directness": "primary", "doi": "10.3389/fendo.2025.1599879", "risk_of_bias": "not appraised in public sidecar", "study": "Combination metformin and liraglutide in PCOS: clinical efficacy in women and preclinical insights from gut microbiome modulation in rats"}, {"directness": "primary", "doi": "10.1001/jamainternmed.2025.5684", "risk_of_bias": "not appraised in public sidecar", "study": "Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes"}, {"directness": "primary", "doi": "10.1097/MD.0000000000039026", "risk_of_bias": "not appraised in public sidecar", "study": "Retinopathy risk factors in patients with type 2 diabetes on liraglutide"}, {"directness": "primary", "doi": "10.4274/jcrpe.galenos.2024.2023-10-10", "risk_of_bias": "not appraised in public sidecar", "study": "Liraglutide Treatment Improves Glycaemic Dysregulation, Body Composition, Cardiometabolic Variables and Uncontrolled Eating Behaviour in Adolescents with Severe Obesity"}, {"directness": "primary", "doi": "10.4103/aca.aca_214_20", "risk_of_bias": "not appraised in public sidecar", "study": "Comparison of Glucose Control by Added Liraglutide to Only Insulin Infusion in Diabetic Patient Undergoing Cardiac Surgery: A Preliminary Randomized-Controlled Trial"}, {"directness": "primary", "doi": "10.1111/cts.70127", "risk_of_bias": "not appraised in public sidecar", "study": "Once‐Weekly Semaglutide Versus Once‐Daily Liraglutide for Weight Loss in Adults: A Meta‐Analysis of Randomized Controlled Trials"}, {"directness": "review-level", "doi": "10.1111/dom.70322", "risk_of_bias": "not appraised in public sidecar", "study": "GLP ‐1 receptor agonists for treating obesity without diabetes: A systematic review and meta‐analysis of economic evaluations"}, {"directness": "review-level", "doi": "10.1111/dom.70028", "risk_of_bias": "not appraised in public sidecar", "study": "Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta‐analysis"}, {"directness": "primary", "doi": "10.1097/MD.0000000000040438", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of 3-month liraglutide treatment on oxidative stress and inflammation in type 2 diabetes patients with different urinary albumin-to-creatinine ratio categories"}, {"directness": "review-level", "doi": "10.1111/dom.70298", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials"}, {"directness": "review-level", "doi": "10.1186/s12902-026-02248-4", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and safety of GLP-1 receptor agonists for adolescents and children with obesity: a meta-analysis of randomized controlled trials"}, {"directness": "primary", "doi": "10.1136/bmjopen-2024-095382", "risk_of_bias": "not appraised in public sidecar", "study": "Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase"}, {"directness": "review-level", "doi": "10.1097/MD.0000000000037432", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials"}, {"directness": "primary", "doi": "10.1111/cob.70079", "risk_of_bias": "not appraised in public sidecar", "study": "Exploratory Analysis of Liraglutide Effects on Obstructive Sleep Apnea and Health‐Related Quality of Life in Individuals With Obesity and COPD: A Secondary Analysis of a Randomised Controlled Trial"}, {"directness": "primary", "doi": "10.1016/j.ocarto.2024.100562", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of weight loss and liraglutide on neutrophil gelatinase-associated lipocalin levels among individuals with overweight and knee osteoarthritis: Exploratory analyses of a randomized controlled trial"}, {"directness": "review-level", "doi": "10.1097/MD.0000000000046173", "risk_of_bias": "not appraised in public sidecar", "study": "Assessing the shadows: A meta-analysis of GLP-1 agonists and suicidal ideation"}, {"directness": "primary", "doi": "10.4093/dmj.2022.0342", "risk_of_bias": "not appraised in public sidecar", "study": "Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial"}, {"directness": "primary", "doi": "10.1136/bmjopen-2025-110759", "risk_of_bias": "not appraised in public sidecar", "study": "Preventive effect of liraglutide on postoperative delirium in elderly patients undergoing cardiac surgery: protocol for a single-centre, randomised, double-blind, placebo-controlled trial"}, {"directness": "primary", "doi": "10.1001/jamapsychiatry.2024.3599", "risk_of_bias": "not appraised in public sidecar", "study": "Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder"}, {"directness": "primary", "doi": "10.1038/s41390-025-04537-5", "risk_of_bias": "not appraised in public sidecar", "study": "Long-term administration of liraglutide for weight management in pediatric patients under 18 years: evidence from 7 randomized controlled trials."}, {"directness": "primary", "doi": "10.1371/journal.pone.0341745", "risk_of_bias": "not appraised in public sidecar", "study": "Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching"}, {"directness": "primary", "doi": "10.3389/fendo.2025.1629157", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of liraglutide on depressive symptoms in overweight or obese patients with type 2 diabetes: protocol for a pilot randomized controlled trial"}, {"directness": "review-level", "doi": "10.1101/2025.05.12.25327466", "risk_of_bias": "not appraised in public sidecar", "study": "Real-world cardiovascular effects of liraglutide: transportability analysis of the LEADER trial"}, {"directness": "primary", "doi": "10.51866/cr.886", "risk_of_bias": "not appraised in public sidecar", "study": "Suspected liraglutide (glucagon-like peptide-1 receptor agonist)-induced hyperthyroidism: A case report"}, {"directness": "review-level", "doi": "10.1007/s11695-025-07856-y", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of GLP- 1 Receptor Agonists in the Management of Weight Recurrence or Suboptimal Clinical Response after Undergoing Metabolic Bariatric Surgeries: A Meta-Analysis."}, {"directness": "review-level", "doi": "10.1111/dom.70301", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and safety of liraglutide in non-alcoholic fatty liver disease with or without type 2 diabetes: A systematic review and meta-analysis."}, {"directness": "review-level", "doi": "10.1016/j.diabres.2026.113400", "risk_of_bias": "not appraised in public sidecar", "study": "GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of efficacy, metabolic effects, and safety."}, {"directness": "review-level", "doi": "10.1097/MD.0000000000044917", "risk_of_bias": "not appraised in public sidecar", "study": "New developments in GLP-1 agonist therapy for gestational diabetes: Systematic review on liraglutide, semaglutide, and exenatide from ClinicalTrials.gov"}, {"directness": "primary", "doi": "10.5041/RMMJ.10565", "risk_of_bias": "not appraised in public sidecar", "study": "Incretin Analogues for Weight Reduction in Non-Diabetic Obese: A Review of Liraglutide, Semaglutide, and Tirzepatide Beyond Glycemic Control"}, {"directness": "review-level", "doi": "10.1111/dom.70452", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis."}, {"directness": "review-level", "doi": "10.15690/pf.v22i2.2871", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of Liraglutide in Adolescents Aged 12–15 Years with Obesity: a Prospective 24-week Observational"}, {"directness": "primary", "doi": "10.1590/1414-431X20198652", "risk_of_bias": "not appraised in public sidecar", "study": "Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: a pilot study"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen."}]}
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "d8f38608-04e9-4baf-a98a-b15cef29f955",
"researka_submission_id": "3b55c07b-acb3-4a2c-bd24-ae0c9c9f8c27",
"sidecar_name": "risk_of_bias.json",
"sidecar_url": "https://api.researka.org/publications/d8f38608-04e9-4baf-a98a-b15cef29f955/sidecars/risk_of_bias.json"
}